<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02666794</url>
  </required_header>
  <id_info>
    <org_study_id>45992815000000068</org_study_id>
    <nct_id>NCT02666794</nct_id>
  </id_info>
  <brief_title>Impact of Labor Analgesia on Serum Catecholamine Levels, Fetal Heart Rate and Uterine Tone in Pregnancies With Comorbidities</brief_title>
  <official_title>Comparative Clinical Trial on the Impact of Labor Analgesia on Serum Catecholamine Levels, Fetal Heart Rate and Uterine Tone in Pregnancies With Comorbidities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The combined spinal-epidural analgesia during the labor has been associated with more changes&#xD;
      in fetal heart rate and uterine tonus than epidural analgesia, and the opinions in literature&#xD;
      are not fully consolidated. The decrease of cathecolamines levels are implicated in this&#xD;
      changes, but there is not studies in patients with comorbidities or with modern labor&#xD;
      analgesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      INTRODUCTION: The combined spinal-epidural analgesia during the labor has been associated&#xD;
      with more changes in fetal heart rate and uterine tonus than epidural analgesia, and the&#xD;
      opinions in literature are not fully consolidated. The decrease of cathecolamines levels are&#xD;
      implicated in this changes, but there is not studies in patients with comorbidities or with&#xD;
      modern labor analgesia.&#xD;
&#xD;
      OBJECTIVES: To estimate the effects of combined spinal-epidural analgesia and epidural&#xD;
      analgesia on maternal cathecolamines levels, fetal heart rate and uterine basal tone in&#xD;
      pregnancies with comorbidities&#xD;
&#xD;
      METHOD: This is experimental, analytical, prospective, randomized, double-blind. It will&#xD;
      include 50 pregnant women with gestations with comorbidities, admitted on labor. Pregnants&#xD;
      will be randomly divided into two groups: combined spinal-epidural analgesia and epidural&#xD;
      analgesia. The primary dependent variables to be evaluated will be the change in&#xD;
      cathecolamine levels, uterine tone and changes in the fetal heart rate.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 12, 2017</start_date>
  <completion_date type="Actual">October 16, 2020</completion_date>
  <primary_completion_date type="Actual">October 16, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cathecolamines levels</measure>
    <time_frame>at the moment of analgesia and 20 minutes after</time_frame>
    <description>Pattern of cathecolamines levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fetal bradycardia</measure>
    <time_frame>15 minutes before analgesia and 30 minutes after continuously</time_frame>
    <description>Fetal bradycardia is defined as the baseline drops to less than 100 bpm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Increase in uterine tone</measure>
    <time_frame>15 minutes before analgesia and 30 minutes after continuously</time_frame>
    <description>Increase in uterine tone (qualitative measure)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal hipotension</measure>
    <time_frame>30 minutes after analgesia (measures every 5 minutes)</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain scores</measure>
    <time_frame>20 minutes after analgesia (measures every 5 minutes)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>APGAR score</measure>
    <time_frame>At birth</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fetal acidosis</measure>
    <time_frame>At birth</time_frame>
    <description>umbilical arterial blood</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Fetal Bradycardia</condition>
  <condition>Hypertonic Uterine</condition>
  <condition>Catecholamines</condition>
  <arm_group>
    <arm_group_label>Puncture epidural</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women in labor the epidural group will receive epidural bupivacaine with vasoconstrictor 0.125% 10 ml plus 20 micrograms sufentanil, followed by the placement of the epidural catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The mothers of the combined spinal-epidural analgesia group will receive intrathecal hyperbaric bupivacaine solution 0.5% 2.5 mg plus 5.0 micrograms of sufentanil and plus 60 micrograms of morphine, followed by placement of an epidural catheter to the catheter through technical needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural bupivacaine with vasoconstrictor 0.125%</intervention_name>
    <description>10 ml</description>
    <arm_group_label>Puncture epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epidural sufentanil</intervention_name>
    <description>20 mcg</description>
    <arm_group_label>Puncture epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placement of the epidural catheter</intervention_name>
    <description>Placement of the epidural catheter</description>
    <arm_group_label>Puncture epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal hyperbaric bupivacaine solution 0.5%</intervention_name>
    <description>2.5 mg</description>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal morphine</intervention_name>
    <description>60 mcg</description>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placement of an epidural catheter to the catheter through technical needle</intervention_name>
    <description>Placement of an epidural catheter to the catheter through technical needle</description>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal sufentanil</intervention_name>
    <description>5 mcg</description>
    <arm_group_label>Puncture combined spinal-epidural</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  previous diagnosis of intrauterine growth restriction&#xD;
&#xD;
          -  maternal diseases that attend with chronic placental insufficiency (obesity, diabetes,&#xD;
             arterial hypertension, kidney disease, thrombophilias, heart disease or lung disease&#xD;
             for example)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients ASA I or IV&#xD;
&#xD;
          -  contraindications regional analgesia&#xD;
&#xD;
          -  prior use of systemic opioids for the relief of labor pain&#xD;
&#xD;
          -  amniotic, and maternal infection&#xD;
&#xD;
          -  known fetal diseases&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shirley Santos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesiologist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shirley Andrade Santos</name>
      <address>
        <city>São Paulo</city>
        <zip>05408000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Baschat AA. Fetal growth restriction - from observation to intervention. J Perinat Med. 2010 May;38(3):239-46. doi: 10.1515/jpm.2010.041. Review.</citation>
    <PMID>20205623</PMID>
  </reference>
  <results_reference>
    <citation>Abrão KC, Francisco RPV, Miyadahira S, Cicarelli DD, Zugaib M. Elevation of uterine basal tone and fetal heart rate abnormalities after labor analgesia: a randomized controlled trial. Obstet Gynecol. 2009 Jan;113(1):41-47. doi: 10.1097/AOG.0b013e31818f5eb6.</citation>
    <PMID>19104358</PMID>
  </results_reference>
  <results_reference>
    <citation>Van de Velde M, Vercauteren M, Vandermeersch E. Fetal heart rate abnormalities after regional analgesia for labor pain: the effect of intrathecal opioids. Reg Anesth Pain Med. 2001 May-Jun;26(3):257-62.</citation>
    <PMID>11359226</PMID>
  </results_reference>
  <results_reference>
    <citation>Nielsen PE, Erickson JR, Abouleish EI, Perriatt S, Sheppard C. Fetal heart rate changes after intrathecal sufentanil or epidural bupivacaine for labor analgesia: incidence and clinical significance. Anesth Analg. 1996 Oct;83(4):742-6.</citation>
    <PMID>8831313</PMID>
  </results_reference>
  <results_reference>
    <citation>Collis RE, Davies DW, Aveling W. Randomised comparison of combined spinal-epidural and standard epidural analgesia in labour. Lancet. 1995 Jun 3;345(8962):1413-6.</citation>
    <PMID>7760614</PMID>
  </results_reference>
  <results_reference>
    <citation>Nakamura G, Ganem EM, Rugolo LM, Castiglia YM. Effects on mother and fetus of epidural and combined spinal-epidural techniques for labor analgesia. Rev Assoc Med Bras (1992). 2009 Jul-Aug;55(4):405-9.</citation>
    <PMID>19750306</PMID>
  </results_reference>
  <results_reference>
    <citation>Patel NP, El-Wahab N, Fernando R, Wilson S, Robson SC, Columb MO, Lyons GR. Fetal effects of combined spinal-epidural vs epidural labour analgesia: a prospective, randomised double-blind study. Anaesthesia. 2014 May;69(5):458-67. doi: 10.1111/anae.12602.</citation>
    <PMID>24738803</PMID>
  </results_reference>
  <results_reference>
    <citation>Simmons SW, Taghizadeh N, Dennis AT, Hughes D, Cyna AM. Combined spinal-epidural versus epidural analgesia in labour. Cochrane Database Syst Rev. 2012 Oct 17;10:CD003401. doi: 10.1002/14651858.CD003401.pub3. Review.</citation>
    <PMID>23076897</PMID>
  </results_reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 21, 2015</study_first_submitted>
  <study_first_submitted_qc>January 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2016</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>SHIRLEY ANDRADE SANTOS</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>fetal bradycardia</keyword>
  <keyword>hypertonic uterine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vasoconstrictor Agents</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Dsuvia</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

